A newer-generation stroke drug is outperforming the standard clot buster at Ascension Seton hospitals in Central Texas. Dell Med neurologist Steven Warach, M.D., explains how tenecteplase saves both time and money when it comes to treating ischemic stroke.
Dell Medical School’s Division of Global Health recaps the latest Puentes summit that convened international partners and focused on advancing health equity and health partnerships with Mexico.
For many, the COVID-19 pandemic spelled disaster. Dell Med teams partnered with community organizations and volunteers across Central Texas to reach those most vulnerable.
Justin Rousseau leverages both his medical expertise as a neurologist and training in biomedical informatics to support the many ways data can transform health — both in and out of the clinic.